OPALEYE MANAGEMENT INC. sold 41.4% of their position (28.32K shares) of ETON PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $1.06M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/16/2026ACC: 0001493152-26-033577
10% Owner
Since Mar 2020
-28.32K
Net shares
Net seller
$1.06M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
28.32K disposed
Non-Derivative Transactions2
Common Stock, par value $0.001 per share
Indirect
Shares
−15K
Price / share
$37.54
Trade value
$563.15K
% of position
0.6%
7/14/2026
2.68M→2.67M
Common Stock, par value $0.001 per share
Indirect
Shares
−13.31K
Price / share
$37.54
Trade value
$499.89K
% of position
25.0%
7/14/2026
53.31K→40K
Total
Net shares
−28.32K
Net value
-$1.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 7/14/2026 | S · Sale | −15K | $37.54 | $563.15K | 0.6% | 2.68M | 2.67M |
| Common Stock, par value $0.001 per share Indirect | 7/14/2026 | S · Sale | −13.31K | $37.54 | $499.89K | 25.0% | 53.31K | 40K |
| Total | −28.32K | -$1.06M | ||||||
Derivative Transactions0
No derivative transactions reported